SCHEMBL31745635

CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C

nearest known ligand 0.70

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.64

▸	NPY4R	P50391	8/20	0.64

▸	NPY5R	Q15761	8/20	0.64

▸	NPY1R	P25929	6/20	0.64

▸	CALCR	P30988	4/20	0.64

▸	TFPI	P10646	4/20	0.63

▸	CXCL8	P10145	1/20	0.58

▸	CRHR1	P34998	1/20	0.58

▸	CRHR2	Q13324	1/20	0.58

▸	RAMP3	O60896	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31295738	0.88	TFPI (0.64)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30567759	0.88	CALCR (0.72)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29526878	0.87	NPY2R (0.63)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31105560	0.87	NPY2R (0.72)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31182922	0.87	CALCR (0.71)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30495811	0.87	NPY2R (0.66)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29387110	0.87	CALCR (0.60)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29523674	0.86	CALCR (0.70)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31182900	0.86	CALCR (0.67)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30658279	0.86	NPY2R (0.73)	NPY2RNPY4RNPY5RNPY1RCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20250381281-A1	METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES	BARINTHUS BIOTHERAPEUTICS NORTH AMERICA INC (US)	2025-12-18	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20250381281-A1	METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES	VIP, HM13, SPPL2B	NPY2R 1174/4885NPY4R 1087/4885NPY5R 1326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.